Page 31 - SFHN0419finalSP.qxp_Page layout

What’s New...

FAU Receives $3 Million Grant
for Dementia Prevention Initiative

A leading neuroscientist at Florida Atlantic University’s Schmidt College of
Medicine has received a $3 million, three-year grant from The Harry T. Mangurian,
Jr. Foundation to expand the scope and reach of the Dementia Prevention Initiative
(DPI).
Launched in 2017 with a $1 million grant from The Harry T. Mangurian, Jr.
Foundation, FAU’s DPI has received widespread interest and is now a large longitudi-
nal study of brain aging and dementia. This new grant will enable FAU to continue
research and follow patients for an additional three years, to share data with other
investigators, to provide training, and to distribute information publicly.
Developed by James E. Galvin, M.D., M.P.H., principal investigator and director of
FAU’s Comprehensive Center for Brain Health in the Schmidt College of Medicine,
the DPI uses the latest advances in genetics, biology and the molecular bases of dis-
ease and incorporates personalized and tailor-made evaluation and prevention plans
to reduce risk.
In this program, Galvin and his team are examining novel biomarkers and periph-
eral predictors of disease such as physical performance, retinal imaging using optical
coherence tomography, and gait analyses. They also are working with companies to
develop novel blood tests to improve diagnosis and prediction.
“If we can identify changes in physical activity and gait, examine retinal and visual
tests as well as blood-based markers, this information may provide insight into those
individuals at-risk for disease who are likely to progress to clinically detectable symp-
toms,” said Galvin.

Holy Cross Offers New,

More Comfortable
Mammogram

The Dorothy Mangurian Compre hensive
Women's Center at Holy Cross HealthPlex is
the first in Broward County to offer the
SmartCurve™ breast stabilization system,
which is clinically proven to deliver a more
comfortable mammogram without compro-
mising image quality, workflow or dose. This
latest innovation is part of Holy Cross' ongoing commitment to superior breast cancer
detection and has the potential to increase screening volume and compliance for the
countless women who have reported avoiding regular mammograms due in large part
to the fear of discomfort associated with breast compression. The SmartCurve system
is available exclusively with Hologic’s Genius™ 3D Mammography™ exam, which is
currently in use by Holy Cross and detects more invasive cancers, reduces false pos-
itives, and is FDA approved as superior to conventional 2D mammography for all
women, including those with dense breasts.
The SmartCurve system features a proprietary curved surface that mirrors the
shape of a woman’s breast to reduce pinching and allow better distribution of force
over the entire breast. In a recent clinical study comparing the SmartCurve breast sta-
201999
bilization system to traditional flat paddle compression, the SmartCurve system th th
l SFHHA H lth e Summmit
improved comfort in 93 percent of women who reported moderate to severe discom- 2019 13 13 A Annuual SFHHA Healthcar S it
fort with standard compression. In addition, 95 percent of those surveyed would rec-
ommend facilities that use the system.
INNOV TIONSAVA M& ARKE DISRUPT PT ORS
June 12-13, 2019 | Signature Grannd, Davie FL
Memorial Hospital Pembroke Completes
a ion or
Wednesday, June 12, 20019 F or R egis trat
First Inspire® Upper Airway Stimulation 3:30 pm - Registration Sp onsorships:
s
4:00 pm - Opening Keynote S Session (ACHE 1.5 credit) http:t p // // // / /b . it lyy 2 / / y/ y/ 0 19SFHHA SUMMIT
aree D
vatioon in Healthc
(UAS) Therapy Procedure • Disruption and Innova ., FFAA CPP, , FFAA elivve erryy Q Ques t ions: spp onsors@sr @ f hha. c om

Farzanna Sherene Haffizulla, M.D

MWWAA

Assistant D ean ffoor Communityy & Global Health, Nova Southeastern Univversity,, y
Dr. Kiran C. Patel College of Alloopathic Medicine (NSU MD)
Memorial Hospital Pembroke at Memorial Healthcare System has completed the first 5:30 pm – Cocktail Reception & Networking in Exhibit Hall
Inspire Upper Airway Stimulation (UAS) therapy procedure at its Pembroke Pines facil- 6:45 pm - VIP Dinner with Special Guest Speaker
ity lead by Eamon J. McLaughlin, M.D. Inspire therapy is an FDA-approved break- Thursday, June 13, 2019 Member:: $125
through obstructive sleep apnea (OSA) treatment option for those who cannot use 7:30 am – Registration & Breakfast in Exhibit Hall
Continuous Positive Airway Pressure (CPAP) therapy. 8:30 am – Opening Session: Disruption: Changing Deliv erryy off Healthc arree F ( or b t o h day s)
Inspire therapy works inside the body with a patient’s natural breathing process to 10:15 am - 11:15am. Tw (SF HHA , SF HIM , AMSS CHE,
Two Breakout Sessions (Choose A or B)

treat sleep apnea. Mild stimulation keeps the airway open during sleep, allowing oxy- Session A gyy:: Innova ativvee and Disruptive Tvve Teechnology DCMA , B CMA PB,A CMS)
•
Health Information TTeechnolo
v
gen to flow naturally. The patient uses a small handheld remote to turn Inspire on Session B

Session B

v
before bed and off when they wake up. • Nurse Innova ation: The FFu uturree

T
apperr,, BDO

- Gina Ta

The Inspire system is implanted during a short, outpatient procedure. The system is eadorr,, BDO

- Dr. Karen M

placed under the skin of the neck and chest through three small incisions. Most patients 10:15 am - 11:45 am Breakout Sessions Non-Membe er: $200
vation in Alt

ernativvee Payment Models

vations: Innova
return home the same day and take over-the-counter pain medications as needed. The • • F Fiinancial Innova ( (CClosed session by invitation by only) (ACHE 1.5 credit)
CEO Exxcchange
safety and efficacy of Inspire therapy was evaluated during the STAR clinical trial. Five- 11:15 am - Live Interactive Demo Event in Exhibit Hall F ( or b t o h day s)
year STAR trial outcomes show patients using Inspire therapy experience significant 11:50 am – Closing Session and Lunch
ace
3.0 A
ace Credit

vation and Disruption in Healthc

reductions in sleep apnea events and significant improvements in quality of life meas- What’ss Ahead for Innovaation and Disruption in HealthcarvWhat ’s Ahead for Innova arree??ree?? 30 ACHE FaCHE F Fa Face t FaF Fa F o to ace Cr edits s
ures. As of May 2018, there have been over 50 peer-reviewed publications on Inspire

I

I

therapy. These publications show results consistent with those seen in the STAR trial. www w. .SFHHA.com I HKT) P Ƈ CQ4 W5 F VK # G Dania Beach I FL
South Florida Hospital News southfloridahospitalnews.com April 2019 31